Live Breaking News & Updates on All cohorts

Stay updated with breaking news from All cohorts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting

- Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – - ODYSSEY Phase 2b Clinical Trial Enrollment is On Track with Data Expected in Q3...

Texas , United-states , Germany , Bulgaria , Rahul-khurana , George-lasezkay , Remy-bernarda , Jenny-kobin , Davidm-brown , Clearside-biomedical-inc , Retina-society , Retina-international

Clearside Biomedical Positive OASIS and Extension Study

- Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – - ODYSSEY Phase 2b Clinical Trial...

Texas , United-states , Germany , Bulgaria , George-lasezkay , Davidm-brown , Remy-bernarda , Rahul-khurana , Jenny-kobin , Clearside-biomedical-inc , Exchange-commission , Retina-society

Clearside Biomedical Presents Compelling Data at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting

ALPHARETTA, Ga., April 27, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,... | April 27, 2023

Massachusetts , United-states , Canada , China , India , South-korea , New-zealand , Australia , Triamcinolone-acetonide-suprachoroidal , Remy-bernarda , Dennism-marcus , George-lasezkay

Clearside Biomedical Announces Plans for ODYSSEY Phase 2b

- Multiple U.S. Clinical Sites to Begin Enrolling ODYSSEY Participants This Quarter - - ODYSSEY Topline Results Expected in Q3 2024 - ALPHARETTA, Ga.,...

George-lasezkay , Jenny-kobin , Remy-bernarda , Exchange-commission , Clearside-biomedical-inc , Us-food-drug-administration , Nasdaq , Begin-enrolling , Results-expected , Chief-executive-officer , Drug-administration

Clearside Biomedical Announces Positive 6-Month Results

- Suprachoroidal CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders -...

Phoenix , Arizona , United-states , University-of-arizona , Markr-barakat , Thomasa-ciulla , George-lasezkay , Retinal-research-institute , University-of-arizona-college-medicine , Nasdaq , Clearside-biomedical-inc , Favorable-safety-data

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...

Australia , Japan , Brazil , Hank-fuchs , Traci-mccarty , European-commission , Drug-administration , Biomarin-pharmaceutical-inc , Nasdaq , Exchange-commission , Worldwide-research , Health-authorities

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...

Australia , Japan , Brazil , Hank-fuchs , Traci-mccarty , European-commission , Drug-administration , Biomarin-pharmaceutical-inc , Nasdaq , Exchange-commission , Worldwide-research , Health-authorities

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , Japan , Brazil , Hank-fuchs , Traci-mccarty , European-commission , Drug-administration , Biomarin-pharmaceutical-inc , Nasdaq , Exchange-commission , Worldwide-research , Health-authorities

Corona in NRW: Keine Probleme mit Corona-Regeln bei der Bundestagswahl

Corona in NRW: Keine Probleme mit Corona-Regeln bei der Bundestagswahl
ksta.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksta.de Daily Mail and Mail on Sunday newspapers.

Kreis-hoxter , Nordrhein-westfalen , Germany , Monchengladbach , Lower-rhine , Netherlands-general- , Netherlands , Schleswig , Schleswig-holstein , Kreis-gutersloh , Ennepe , Westfalen

Corona in NRW: Weniger Patienten in Krankenhäusern – Inzidenz sinkt leicht

Corona in NRW: Weniger Patienten in Krankenhäusern – Inzidenz sinkt leicht
rundschau-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rundschau-online.de Daily Mail and Mail on Sunday newspapers.

Kreis-hoxter , Nordrhein-westfalen , Germany , Monchengladbach , Lower-rhine , Netherlands-general- , Netherlands , Schleswig , Schleswig-holstein , Kreis-gutersloh , Ennepe , Westfalen